PRDM9 and head and neck squamous cell carcinoma: As a histone methyltransferase, a previous study indicated that NSD1 mutations alter the methylation of histone H3 at K36 (H3K36), subsequently blocking cellular differentiation and promoting oncogenesis in HPV-negative HNSCC [22].